During the last session, Protalix BioTherapeutics Inc (AMEX:PLX)’s traded shares were 0.46 million, with the beta value of the company hitting 0.73. The 52-week high
Protalix BioTherapeutics Inc (AMEX:PLX)’s traded shares stood at 0.41 million during the last session, with the company’s beta value hitting 0.74. At the close of
During the last session, Protalix BioTherapeutics Inc (AMEX:PLX)’s traded shares were 0.55 million, with the beta value of the company hitting 0.69. At the end
In today’s recent session, 0.83 million shares of the Protalix BioTherapeutics Inc (AMEX:PLX) have been traded, and its beta is 0.64. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
